Top Markets
#1 QuantixAI QuantixAI +105.36%
#2 龙虾 (Lobster) 龙虾 (Lobster) +53.19%
#3 Pons Pons +30.05%
#4 MetaDAO MetaDAO +29.39%
#5 Rain Rain +23.12%
#6 Bedrock Bedrock +20.74%
#7 Ontology Gas Ontology Gas +19.19%
#8 Prom Prom +17.17%
#9 Humanity Humanity +14.94%
#10 Janction Janction +13.74%
Coin of the day
QuantixAI QuantixAI
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Pozycja w akcjach #20256
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Cena akcji
$1.90
Kapitalizacja rynkowa
$135.79M
Zmiana (1 dzień)
-0.50%
Zmiana (1 rok)
20.89%
Kraj
TW
Handel Sinew Pharma Inc. (6634)

Kategoria

Healthcare
Zyski dla Sinew Pharma Inc. (6634)
Zyski w 2026 TTM: 0
Według najnowszych raportów finansowych Sinew Pharma Inc., obecny zysk firmy wynosi 0. W roku 2026 firma osiągnęła zysk w wysokości 0, równa się zysku z roku 2026, który wynosił 0. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Sinew Pharma Inc. od 2026 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
Za mało danych dla podanych dat.
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH